The FDA label for semaglutide products includes a warning to monitor renal function in patients experiencing severe adverse gastrointestinal reactions
Research published in Cell Metabolism demonstrated significant effects on insulin sensitivity, metabolic flexibility, and exercise-mimetic activity
Ahmed LA, Salem HA, Attia AS, Agha AM
Statistica (data analysis software system), version 13
No, GLP-1 receptor agonists are not approved by the MHRA for treating alcohol use disorder
From this cohort, 45 women [15 without mood disorders and 30 with mood disorders (Major depression and Bipolar disorder)] were selected at 18 months postpartum, the depression and suicide risk were assessed using the Mini-International Neuropsychiatric Interview Plus (MINI-Plus) instrument, module A and C, respectively